Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago

Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and mortality worldwide. Direct-acting antiviral (DAA) therapy leads to high cure rates. However, persons who inject drugs (PWID) are at risk for reinfection after cure and may require multiple DAA treatments to reach the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatara, Eric, Gutfraind, Alexander, Collier, Nicholson T., Echevarria, Desarae, Cotler, Scott J., Major, Marian E., Ozik, Jonathan, Dahari, Harel, Boodram, Basmattee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912265/
https://www.ncbi.nlm.nih.gov/pubmed/35271634
http://dx.doi.org/10.1371/journal.pone.0264983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912265/
https://www.ncbi.nlm.nih.gov/pubmed/35271634
http://dx.doi.org/10.1371/journal.pone.0264983

Ejemplares similares